Realcan(SZ:002589) Zheng Quan Zhi Xing·2025-09-05 13:13Summary of Key Points Core Viewpoint The company, Ruikang Pharmaceutical Group Co., Ltd., has revised its Articles of Association and certain governance systems, which will be submitted for shareholder approval. The revisions are in accordance with relevant laws and regulations, reflecting the company's actual situation. Group 1: Revision of Articles of Association - The company has made amendments to its Articles of Association based on the Company Law of the People's Republic of China and other relevant regulations [1][2][3] - The revised Articles of Association will be submitted for approval at the upcoming shareholders' meeting [1][2] - The updated Articles of Association have been published on the official website for public access [1] Group 2: Governance Structure Changes - The legal representative of the company will be the director responsible for executing company affairs, and the resignation of the legal representative will require the appointment of a new representative within thirty days [2][3] - The company will bear civil liability for the legal activities conducted by its legal representative, and may seek compensation from the representative if there is fault [2][3] - The company’s governance structure aims to ensure compliance and operational efficiency, enhancing shareholder value and corporate responsibility [4][5]